Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
$0.00
$0.00
$0.00
$0.03
$5K0.9517,979 shs1,636 shs
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
$1.12
$1.12
$0.63
$5.07
$13.13M2.29210,209 shsN/A
UPHL
UpHealth
$0.00
$0.00
$0.00
$0.55
$4K0.857,881 shs965 shs
Vsee Health, Inc. stock logo
VSEE
Vsee Health
$1.14
-0.8%
$1.16
$1.00
$14.47
$4.11MN/A1.02 million shs47,972 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00%0.00%-50.00%-50.00%-98.90%
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
0.00%0.00%0.00%0.00%0.00%
UPHL
UpHealth
0.00%0.00%0.00%0.00%-99.95%
Vsee Health, Inc. stock logo
VSEE
Vsee Health
-0.79%+4.59%-0.44%-11.63%+113,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
N/AN/AN/AN/AN/AN/AN/AN/A
UPHL
UpHealth
N/AN/AN/AN/AN/AN/AN/AN/A
Vsee Health, Inc. stock logo
VSEE
Vsee Health
1.4937 of 5 stars
2.03.00.00.02.70.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00
N/AN/AN/A
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
0.00
N/AN/AN/A
UPHL
UpHealth
0.00
N/AN/AN/A
Vsee Health, Inc. stock logo
VSEE
Vsee Health
4.00
Strong Buy$5.00338.60% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/A
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
$3.88M3.38N/AN/A$1.37 per share0.82
UPHL
UpHealth
$130M0.00N/AN/A$3.10 per share0.00
Vsee Health, Inc. stock logo
VSEE
Vsee Health
$6.38M0.64N/AN/A($3.40) per share-0.34
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
-$39.76MN/A0.00N/AN/AN/AN/A7/21/2025 (Estimated)
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
-$36.69MN/A0.00N/AN/AN/A-91.82%-64.58%N/A
UPHL
UpHealth
-$56.42M-$1.35N/AN/AN/AN/AN/AN/A
Vsee Health, Inc. stock logo
VSEE
Vsee Health
-$4.41MN/A0.00N/AN/A-182.59%-58.26%6/12/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/A
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
N/AN/AN/AN/AN/A
UPHL
UpHealth
N/AN/AN/AN/AN/A
Vsee Health, Inc. stock logo
VSEE
Vsee Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/A
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
N/A
3.51
3.51
UPHL
UpHealth
N/AN/AN/A
Vsee Health, Inc. stock logo
VSEE
Vsee Health
0.16
0.37
0.37

Institutional Ownership

CompanyInstitutional Ownership
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
34.00%
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
12.88%
UPHL
UpHealth
56.10%
Vsee Health, Inc. stock logo
VSEE
Vsee Health
1.01%

Insider Ownership

CompanyInsider Ownership
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
51.40%
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
N/A
UPHL
UpHealth
34.24%
Vsee Health, Inc. stock logo
VSEE
Vsee Health
6.59%
CompanyEmployeesShares OutstandingFree FloatOptionable
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
4049.86 million24.23 millionOptionable
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
1611.72 millionN/ANot Optionable
UPHL
UpHealth
1,75018.93 million12.45 millionNo Data
Vsee Health, Inc. stock logo
VSEE
Vsee Health
N/A3.60 million3.37 millionN/A

Recent News About These Companies

VSee Health unveils AI-driven telenursing platform
VSee Health issues letter to shareholders updating progress
VSee Health initiated with a Buy at Maxim

Media Sentiment Over Time

Better Therapeutics stock logo

Better Therapeutics NASDAQ:BTTX

$0.0001 0.00 (0.00%)
As of 06/11/2025 12:34 PM Eastern

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

Reunion Neuroscience stock logo

Reunion Neuroscience NASDAQ:REUN

Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, develops therapeutic solutions for mental health conditions in North America. The company's lead asset includes RE104, a clinical-stage serotonergic psychedelic therapeutic product for antidepressant applications. It is also developing the RE200 series, which comprises molecules that are structurally designed to be similar to classical psychedelics with selective potency at the target serotonin 2A receptor (5HT2A) for potential chronic treatment in various patient populations and indications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada.

UpHealth NYSE:UPHL

$0.0002 0.00 (0.00%)
As of 06/11/2025 12:51 PM Eastern

UpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services. UpHealth, Inc. is headquartered in Delray Beach, Florida.

Vsee Health stock logo

Vsee Health NASDAQ:VSEE

$1.14 -0.01 (-0.79%)
Closing price 06/11/2025 03:59 PM Eastern
Extended Trading
$1.14 0.00 (0.00%)
As of 06/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.